Matthew Dellatorre
Stock Analyst at Goldman Sachs
(4.62)
# 905
Out of 5,099 analysts
17
Total ratings
92.9%
Success rate
64.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Dellatorre
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Initiated: Hold | $74 | $79.38 | -6.78% | 1 | Oct 19, 2026 | |
| IDXX IDEXX Laboratories | Initiated: Buy | $740 | $560.36 | +32.06% | 1 | Oct 19, 2026 | |
| ELAN Elanco Animal Health | Initiated: Buy | $32 | $23.55 | +35.88% | 1 | Oct 19, 2026 | |
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $21 | $19.18 | +9.49% | 10 | Aug 10, 2026 | |
| VTRS Viatris | Reiterated: Hold | $10 → $12 | $18.66 | n/a | 4 | Oct 22, 2025 |
Zoetis
Oct 19, 2026
Initiated: Hold
Price Target: $74
Current: $79.38
Upside: -6.78%
IDEXX Laboratories
Oct 19, 2026
Initiated: Buy
Price Target: $740
Current: $560.36
Upside: +32.06%
Elanco Animal Health
Oct 19, 2026
Initiated: Buy
Price Target: $32
Current: $23.55
Upside: +35.88%
Amneal Pharmaceuticals
Aug 10, 2026
Reiterated: Buy
Price Target: $21
Current: $19.18
Upside: +9.49%
Viatris
Oct 22, 2025
Reiterated: Hold
Price Target: $10 → $12
Current: $18.66
Upside: n/a